Scientists track rare immune disease to uncover its secrets
NCT ID NCT00867269
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This study follows people with idiopathic CD4+ lymphocytopenia (ICL), a rare condition where the body has too few CD4+ immune cells, raising the risk of serious infections. Researchers aim to learn how the disease progresses, what causes it, and how it affects the body over time. Participants will have yearly check-ups and tests for up to 10 years, but the study does not test any new treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC CD4+ LYMPHOCYTOPENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institutes of Health Clinical Center
RECRUITINGBethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.